BioMarin Pharmaceutical
| Use attributes for filter ! | |
| Valore azionario | BMRN |
|---|---|
| Limitazione di responsabilità | |
| Sede | Novato, California, Stati Uniti |
| Fatturato | 1,31 miliardi USD (2017) |
| Ceo | Jean-Jacques Bienaime |
| Fondazione | marzo 1997 |
| Numero di dipendenti | 2. 581 (2017) |
| Fondatori | Christopher Starr |
| Ph. D. Glen W. Denison Jr | |
| Official site | biomarin.com |
| Stock quote | BMRN |
| Disclaimer | |
| Revenue | 1.86 billion USD |
| Headquarters | Novato |
| California | |
| United States | |
| Number of employees | 2,581 |
| Founded | March 1997 |
| Cto | Greg Guyer |
| Executives | Brian R. Mueller |
| Henry J. Fuchs M.D., Ph.D. | |
| Lon Cardon | |
| Greg Guyer | |
| Jean-Jacques Bienaime | |
| George Eric Davis | |
| Subsidiaries | Prosensa |
| LEAD Therapeutics, Inc. | |
| Okra answer panel email format | Email format |
| Okra answer panel competitors | Competitors |
| Okra answer panel mission statement | Mission statement |
| Okra answer panel history | History |
| Date of Reg. | |
| Date of Upd. | |
| ID | 844807 |
About BioMarin Pharmaceutical
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research is in enzyme replacement therapies.
BioMarin Pharmaceutical Photos
